WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) announced FDA 510(k) clearance of ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System. Zimmer Biomet will conduct a targeted release of ...

Zimmer Biomet Holdings ((ZBH)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...

WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System. This ...

OrthoSensor received FDA clearance for its Verasense sensor-assisted technology to be used with Zimmer Biomet’s Persona Knee System for total knee replacement. 1. The Verasense device provides ...

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 billion, has been making strategic moves to strengthen its market position ...

Zimmer Biomet (ZBH) received the CE Mark for its Persona Revision Knee System. This addition to the Persona family builds on Zimmer Biomet’s commitment to personalized solutions, providing surgeons ...